Ginsenoside Rg1 Protects Rat Cardiomyocyte from Hypoxia/reoxygenation Oxidative Injury Via Antioxidant and Intracellular Calcium Homeostasis.

Dan Zhu,Lei Wu,Chun-Rong Li,Xiao-Wei Wang,Yong-Jie Ma,Zhi-yin Zhong,Hai-Bao Zhao,Jian Cui,Si-Fan Xun,Xiu-Lan Huang,Zhe Zhou,Sheng-Qi Wang
DOI: https://doi.org/10.1002/jcb.22233
2009-01-01
Journal of Cellular Biochemistry
Abstract:Ginsenoside Rg1 is a major active ingredient of Panax notoginseng radix which has demonstrated a number of pharmacological actions including a cardioprotective effect in vivo. This study investigated the protective effect and mechanism of ginsenoside Rg1 in cardiomyocytes hypoxia/reoxygenation (H/R) model. Pretreatment with ginsenoside Rg1 (60-120 mu M) reduced lactate dehydrogenase release and increased cell viability in a dose-dependent manner. Fluorescence analysis demonstrated ginsenoside Rg1 reduced intracellular ROS and suppressed the intracellular [Ca2+] level. Cell lysate detected an increase of T-SOD, CAT, and GSH levels. The myocardial protection of ginsenoside Rg1 during H/R is partially due to its antioxidative effect and intracellular calcium homeostasis. J. Cell. Biochem. 108: 117-124, 2009. (C) 2009 Wiley-Liss, Inc.
What problem does this paper attempt to address?